Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Made-in-China.com to hold online synchronous event for the 127th Canton Fair 2020-06-02 09:48
DevOps Enterprise Summit London Unveils Virtual Program that Promises to Engage Attendees Through a Dynamic Learning Experience for the DevOps Community 2020-06-01 16:03
V Connect Launches Asia Artificial Intelligence Virtual Summit 2020 2020-06-01 11:00
Huawei Global Analysts Summit: Rethink The Seamless AI Experience With Glocal HMS Ecosystem 2020-06-01 11:00
Supermicro CEO Computex Keynote - 5G Infrastructure Innovation 2020-06-01 10:00
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal 2020-06-01 08:45
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies 2020-05-31 20:00
Suntech Awarded a Third Year Top Performer in DNV-GL/PVEL 2020 PV Module Reliability Scorecard 2020-05-31 13:00
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients 2020-05-30 19:00
I-Mab Announces Upcoming Participation at June Conferences 2020-05-29 20:00
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO) 2020-05-29 20:00
Autoliv Provides Market and Business Update, Accelerates Mitigating Measures and Enters Loan Facility With Swedish Export Credit Corporation 2020-05-29 14:57
Gastech Postponed to September 13-16, 2021 2020-05-28 21:36
1 591 592 593 594 595 1229